Another study involving COVID-19 reported a lower immune response (as measured by IFN-γ response against MTb antigen and SARS-CoV-2 S protein antigen) in MTb-COVID-19 and LMTBI-COVID-19 patients when compared to COVID-19 patients (Petrone et al., 2021). This evidence concerns the gene PROS1 and COVID-19.